678 related articles for article (PubMed ID: 24254031)
1. Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model.
Luo B; Li B; Wang W; Liu X; Liu X; Xia Y; Zhang C; Zhang Y; Zhang M; An F
Cardiovasc Drugs Ther; 2014 Feb; 28(1):33-43. PubMed ID: 24254031
[TBL] [Abstract][Full Text] [Related]
2. NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model.
Luo B; Li B; Wang W; Liu X; Xia Y; Zhang C; Zhang M; Zhang Y; An F
PLoS One; 2014; 9(8):e104771. PubMed ID: 25136835
[TBL] [Abstract][Full Text] [Related]
3. The NLRP3 inflammasome and diabetic cardiomyopathy : editorial to: "Rosuvastatin alleviates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome and MAPK pathways in a type 2 diabetes rat model" by Beibei Luo et al.
Singh LP
Cardiovasc Drugs Ther; 2014 Feb; 28(1):5-6. PubMed ID: 24220800
[No Abstract] [Full Text] [Related]
4. NLRP3 inflammasome activation in coronary artery disease: results from prospective and randomized study of treatment with atorvastatin or rosuvastatin.
Satoh M; Tabuchi T; Itoh T; Nakamura M
Clin Sci (Lond); 2014 Feb; 126(3):233-41. PubMed ID: 23944632
[TBL] [Abstract][Full Text] [Related]
5. Activation of the TXNIP/NLRP3 inflammasome pathway contributes to inflammation in diabetic retinopathy: a novel inhibitory effect of minocycline.
Chen W; Zhao M; Zhao S; Lu Q; Ni L; Zou C; Lu L; Xu X; Guan H; Zheng Z; Qiu Q
Inflamm Res; 2017 Feb; 66(2):157-166. PubMed ID: 27785530
[TBL] [Abstract][Full Text] [Related]
6. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X
Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627
[TBL] [Abstract][Full Text] [Related]
7. The purinergic 2X7 receptor participates in renal inflammation and injury induced by high-fat diet: possible role of NLRP3 inflammasome activation.
Solini A; Menini S; Rossi C; Ricci C; Santini E; Blasetti Fantauzzi C; Iacobini C; Pugliese G
J Pathol; 2013 Nov; 231(3):342-53. PubMed ID: 23843215
[TBL] [Abstract][Full Text] [Related]
8. Aloe vera downregulates LPS-induced inflammatory cytokine production and expression of NLRP3 inflammasome in human macrophages.
Budai MM; Varga A; Milesz S; Tőzsér J; Benkő S
Mol Immunol; 2013 Dec; 56(4):471-9. PubMed ID: 23911403
[TBL] [Abstract][Full Text] [Related]
9. Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation.
Zhang H; Chen X; Zong B; Yuan H; Wang Z; Wei Y; Wang X; Liu G; Zhang J; Li S; Cheng G; Wang Y; Ma Y
J Cell Mol Med; 2018 Sep; 22(9):4437-4448. PubMed ID: 29993180
[TBL] [Abstract][Full Text] [Related]
10. Klotho improves diabetic cardiomyopathy by suppressing the NLRP3 inflammasome pathway.
Li X; Li Z; Li B; Zhu X; Lai X
Life Sci; 2019 Oct; 234():116773. PubMed ID: 31422095
[TBL] [Abstract][Full Text] [Related]
11. Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-κB signaling pathway.
Yin Y; Chen F; Wang W; Wang H; Zhang X
Mol Vis; 2017; 23():242-250. PubMed ID: 28465656
[TBL] [Abstract][Full Text] [Related]
12. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
[TBL] [Abstract][Full Text] [Related]
13. Naringin ameliorates the high glucose-induced rat mesangial cell inflammatory reaction by modulating the NLRP3 Inflammasome.
Chen F; Wei G; Xu J; Ma X; Wang Q
BMC Complement Altern Med; 2018 Jun; 18(1):192. PubMed ID: 29929501
[TBL] [Abstract][Full Text] [Related]
14. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway.
Niemi K; Teirilä L; Lappalainen J; Rajamäki K; Baumann MH; Öörni K; Wolff H; Kovanen PT; Matikainen S; Eklund KK
J Immunol; 2011 Jun; 186(11):6119-28. PubMed ID: 21508263
[TBL] [Abstract][Full Text] [Related]
15. Fluorofenidone attenuates interleukin-1β production by interacting with NLRP3 inflammasome in unilateral ureteral obstruction.
Zheng L; Zhang J; Yuan X; Tang J; Qiu S; Peng Z; Yuan Q; Xie Y; Mei W; Tang Y; Meng J; Hu G; Tao L
Nephrology (Carlton); 2018 Jun; 23(6):573-584. PubMed ID: 28437591
[TBL] [Abstract][Full Text] [Related]
16. Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart.
Fender AC; Kleeschulte S; Stolte S; Leineweber K; Kamler M; Bode J; Li N; Dobrev D
Basic Res Cardiol; 2020 Jan; 115(2):10. PubMed ID: 31912235
[TBL] [Abstract][Full Text] [Related]
17. Heparan sulfate inhibits inflammation and improves wound healing by downregulating the NLR family pyrin domain containing 3 (NLRP3) inflammasome in diabetic rats.
Wang T; Zhao J; Zhang J; Mei J; Shao M; Pan Y; Yang W; Jiang Y; Liu F; Jia W
J Diabetes; 2018 Jul; 10(7):556-563. PubMed ID: 29171721
[TBL] [Abstract][Full Text] [Related]
18. Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injury.
Hou Y; Wang Y; He Q; Li L; Xie H; Zhao Y; Zhao J
Behav Brain Res; 2018 Jan; 336():32-39. PubMed ID: 28851669
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed human corneal epithelial cells and environment-induced dry eye patients.
Zheng Q; Ren Y; Reinach PS; Xiao B; Lu H; Zhu Y; Qu J; Chen W
Exp Eye Res; 2015 May; 134():133-40. PubMed ID: 25701684
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide Riboside Ameliorates Hepatic Metaflammation by Modulating NLRP3 Inflammasome in a Rodent Model of Type 2 Diabetes.
Lee HJ; Hong YS; Jun W; Yang SJ
J Med Food; 2015 Nov; 18(11):1207-13. PubMed ID: 25974041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
